Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Pharmacy / 藥學專業學院
  4. Clinical Pharmacy / 臨床藥學研究所
  5. Patterns and Outcomes of Novel Oral Anticoagulants in Real-World Patients with Non-Valvular Atrial Fibrillation
 
  • Details

Patterns and Outcomes of Novel Oral Anticoagulants in Real-World Patients with Non-Valvular Atrial Fibrillation

Date Issued
2016
Date
2016
Author(s)
Huang, Hsin-Yi
DOI
10.6342/NTU201602051
URI
http://ntur.lib.ntu.edu.tw//handle/246246/277178
Abstract
Background: Novel oral anticoagulants (NOACs) recently launched to Taiwan for preventing ischemic stroke among non-vavluar atrial fibrillation patients. However, the effectiveness and safety in real-world clinical practice is still scarce, especially in Asian population. Objective: First, to analyze the prescription patterns of oral antithrombotic agents after the launch of NOACs. Second, to assess the effectiveness and safety between patients who newly initiated NOAC and warfarin among Asian population. Third, we aim to evaluate whether being long-term prescribed warfarin would affect the effectiveness and safety of NOAC. Methods: We used National Health Insurance Research Database (NHIRD) to assess non-valvular atrial fibrillation patients who prescribed dabigatran, rivaroxaban, or warfarin from Jun 1st, 2012 to Dec 31th, 2015. We applied propensity score matching to the Cox proportional hazard model to evaluate the effectiveness and safety between NOACs (including dabigatran and rivaroxaban) and warfarin. The analyses were also repeated to assess different drug groups, dose groups, and elderly patients with at least 65 or 80 years old. The follow-up period was the time from index date to the outcome of interests, switching to or discontinuation of alternative oral anticoagulants, end of the administrative period. Results: Compared with warfarin in the warfarin-naive stratum, NOAC were generally associated with a lower risk of intracranial hemorrhage (HR: 0.45, 95% CI: 0.31-0.66), venous thromboembolism (HR: 0.37, 95% CI: 0.21-0.66), and the composite bleeding events (HR: 0.8, 95% CI: 0.69-0.92), whereas there were no significant differences in 3 the risk of gastrointestinal bleeding. In different dose groups, rivaroxaban 20 mg and 15 mg were associated with a lower risk of ischemic stroke compared with warfarin (HR:0.48, 95%: 0.29-0.80 and HR: 0.69, 95% CI: 0.53-0.90 in rivaroxaban 20 mg and 15 mg, respectively), and rivaroxaban 20 mg was associated with a lower risk of gastrointestinal bleeding (HR:0.47, 95% CI: 0.24-0.90). In elderly, rivaroxaban was associated with lower risk of ischemic stroke compared with warfarin in patients with at least 65 years old (HR: 0.71, 95% CI: 0.56-0.89) and 80 years old (HR: 0.65, 95% 0.46-0.61). In warfarin-experienced stratum, NOAC was associated with lower risk of intracranial hemorrhage (HR: 0.38, 95% CI: 0.19-0.78). However, there were no significant differences in the risk of ischemic stroke, transient ischemic attack, venous thromboembolism, and gastrointestinal bleeding. Conclusions: In the ─real-world∥ clinical practice, NOACs were generally associated with a lower risk of intracranial hemorrhage compared with warfarin. Rivaroxaban with a dose equal to or greater than 15 mg may be considered as a sufficient therapeutic dose in preventing thromboembolism events. Moreover, rivaroxaban was found to be a better choice than warfarin in preventing ischemic stroke among elderly patients.
Subjects
Novel oral anticoagulants (NOACs)
Asian
atrial fibrillation
National Health Insurance Research Database (NHIRD)
Type
thesis
File(s)
Loading...
Thumbnail Image
Name

ntu-105-R03451001-1.pdf

Size

23.32 KB

Format

Adobe PDF

Checksum

(MD5):18785f3ff703ac644230483472fb75a9

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science